People | May 01, 2026
Syngene appoints Maninder Kapoor Puri as CHRO and Abhijit Zutshi as CCO
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Both join the leading CRDMO’s executive committee to drive global people strategy and commercial expansion
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Gilenya Capsules, 0.5 mg of Novartis Pharmaceuticals Corporation (Novartis)
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Subscribe To Our Newsletter & Stay Updated
